301 related articles for article (PubMed ID: 18186308)
1. Combination therapy of renin angiotensin system inhibitors and bepridil is useful for maintaining sinus rhythm in patients with atrial fibrillation.
Kawamura M; Ito H; Onuki T; Miyoshi F; Minoura Y; Asano T; Tanno K; Kobayashi Y
J Cardiol; 2007 Dec; 50(6):343-50. PubMed ID: 18186308
[TBL] [Abstract][Full Text] [Related]
2. Relation of interleukin-6 and C-reactive protein levels to sinus maintenance after pharmacological cardioversion in persistent atrial fibrillation.
Fujiki A; Sakamoto T; Nishida K; Mizumaki K; Inoue H
J Cardiovasc Pharmacol; 2007 Sep; 50(3):264-6. PubMed ID: 17878753
[TBL] [Abstract][Full Text] [Related]
3. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
Fazio G; Pizzuto C; Sutera L; Guttilla D; Di Gesaro G; Cascio C; Novo G; Assennato P; Novo S
Minerva Cardioangiol; 2007 Jun; 55(3):311-5. PubMed ID: 17534249
[TBL] [Abstract][Full Text] [Related]
4. [Long-term efficacy of combination therapy using antiarrhythmic agents and angiotensin converting enzyme inhibitor in patients with paroxysmal and persistent atrial fibrillation: importance of the timing of administration].
Komatsu T; Nakamura S; Suzuki O; Horiuchi D; Owada S; Kameda K; Tomita H; Oikawa K; Abe N; Okumura K
J Cardiol; 2003 Feb; 41(2):73-80. PubMed ID: 12649925
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of amiodarone versus bepridil in achieving conversion to sinus rhythm in patients with persistent atrial fibrillation: a randomised trial.
Yamase M; Nakazato Y; Daida H
Heart; 2012 Jul; 98(14):1067-71. PubMed ID: 22689712
[TBL] [Abstract][Full Text] [Related]
6. Correlation between inflammation state and successful medical cardioversion using bepridil for refractory atrial fibrillation.
Nishino M; Mori N; Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
J Cardiol; 2013 Aug; 62(2):117-20. PubMed ID: 23623817
[TBL] [Abstract][Full Text] [Related]
7. Control of rate versus rhythm in rheumatic atrial fibrillation: a randomized study.
Vora A; Karnad D; Goyal V; Naik A; Gupta A; Lokhandwala Y; Kulkarni H; Singh B
Indian Heart J; 2004; 56(2):110-6. PubMed ID: 15377131
[TBL] [Abstract][Full Text] [Related]
8. Catheter ablation vs. amiodarone plus losartan for prevention of atrial fibrillation recurrence in patients with paroxysmal atrial fibrillation.
Lan X; Su L; Ling Z; Liu Z; Wu J; Yang X; Zrenner B; Yin Y
Eur J Clin Invest; 2009 Aug; 39(8):657-63. PubMed ID: 19490069
[TBL] [Abstract][Full Text] [Related]
9. [Long-term clinical efficacy of losartan or perindopril combination therapy with low-dose amiodarone in patients with paroxysmal atrial fibrillation].
Yin YH; Liu ZC; Wu JJ; Dai Y; Su L; Lan XB; Ling ZY; Yang XY; Luo KL
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):299-302. PubMed ID: 16776916
[TBL] [Abstract][Full Text] [Related]
10. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].
Niu F; Huang CX; Jiang H; Yang B; Guo WL; Chen YX; Jin CR; Liu ZM
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):121-3. PubMed ID: 16620720
[TBL] [Abstract][Full Text] [Related]
11. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation.
Al Chekakie MO; Akar JG; Wang F; Al Muradi H; Wu J; Santucci P; Varma N; Wilber DJ
J Cardiovasc Electrophysiol; 2007 Sep; 18(9):942-6. PubMed ID: 17593228
[TBL] [Abstract][Full Text] [Related]
12. Candesartan decreases type III procollagen-N-peptide levels and inflammatory marker levels and maintains sinus rhythm in patients with atrial fibrillation.
Kawamura M; Ito H; Onuki T; Miyoshi F; Watanabe N; Asano T; Tanno K; Kobayashi Y
J Cardiovasc Pharmacol; 2010 May; 55(5):511-7. PubMed ID: 20164787
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation.
Lip GY; Frison L; Grind M
J Intern Med; 2007 Jun; 261(6):577-86. PubMed ID: 17547713
[TBL] [Abstract][Full Text] [Related]
14. Reviewing the future of renin-angiotensin system blockade: the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation.
Ducharme A; Schiffrin EL
Can J Cardiol; 2010 Dec; 26 Suppl E():21E-23E. PubMed ID: 21620287
[TBL] [Abstract][Full Text] [Related]
15. [Effect of surgical treatment of atrial fibrillation on the attainment and maintenance of sinus rhythm in patients undergoing concomitant cardiac surgery--short-term results].
Kolek M; Brát R
Cas Lek Cesk; 2007; 146(4):383-92; discussion 392-5. PubMed ID: 17491249
[TBL] [Abstract][Full Text] [Related]
16. Carvedilol is effective and safe in combination with bepridil for persistent atrial fibrillation and decreases the QT prolongation induced by bepridil therapy.
Kawamura M; Munetsugu Y; Tanno K; Kobayashi Y
J Cardiovasc Pharmacol; 2013 Jan; 61(1):77-82. PubMed ID: 23107870
[TBL] [Abstract][Full Text] [Related]
17. Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction.
Ozaydin M; Varol E; Türker Y; Peker O; Erdoğan D; Doğan A; Ibrişim E
Anadolu Kardiyol Derg; 2010 Apr; 10(2):137-42. PubMed ID: 20382613
[TBL] [Abstract][Full Text] [Related]
18. Maintenance of sinus rhythm and recovery of atrial mechanical function after cardioversion with bepridil or in combination with aprindine in long-lasting persistent atrial fibrillation.
Fujiki A; Tsuneda T; Sakabe M; Nakagawa K; Mizumaki K; Hirai T; Inoue H
Circ J; 2004 Sep; 68(9):834-9. PubMed ID: 15329504
[TBL] [Abstract][Full Text] [Related]
19. [The effect of inhibition of renin-angiotensin system on cardioversion success and recurrences of atrial fibrillation].
Doğan A; Akçay S
Anadolu Kardiyol Derg; 2009 Dec; 9(6):505-11. PubMed ID: 19965325
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening?
Ho SF; O'Mahony MS; Steward JA; Burr ML; Buchalter M
Age Ageing; 2004 Sep; 33(5):488-92. PubMed ID: 15271642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]